← Back to Search

Brain Stimulation for Mobility Improvement in Aging

Led By Clayton W Swanson, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Screening 3 weeks
Treatment Varies
Follow Up 5 minutes, measured two times approximately 3 weeks apart
Awards & highlights

Study Summary

This trial will use brain stimulation to help assess why older adults and stroke survivors often have difficulty turning, a complex walking task which can lead to injury.

Who is the study for?
This trial is for older adults, aged 65 or above, who have some difficulty with walking tasks. They should be able to commit to the study's requirements but not be on CNS-affecting meds, severely obese, or have major health issues like heart disease. Those with metal implants affecting MRI or brain stimulation and severe arthritis are also excluded.Check my eligibility
What is being tested?
The study is examining how non-invasive brain stimulation can help understand and improve turning while walking in older adults and stroke survivors. It aims to link brain activity patterns with the ability to perform complex walking tasks.See study design
What are the potential side effects?
Potential side effects may include discomfort from non-invasive brain stimulation such as mild headaches or scalp sensations during the procedure. There might also be temporary skin irritation from electrode placement.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 minutes, measured two times approximately 3 weeks apart
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 minutes, measured two times approximately 3 weeks apart for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
180 Degree Turn Duration
360 degree Turn Duration
Duration of Cortical Silent Period (CSP) (ms)
+2 more
Secondary outcome measures
Katz Independence Questionnaire

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Transcranial Direct Current SimulationExperimental Treatment1 Intervention
Participants will undergo 20 minutes of 2 mA electrical stimulation to the head through saline soaked electrodes.
Group II: Sham StimulationPlacebo Group1 Intervention
Participants will undergo 30 seconds of 2 mA electrical current to the head through saline soaked electrodes.

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,609 Previous Clinical Trials
3,306,383 Total Patients Enrolled
23 Trials studying Aging
2,769 Patients Enrolled for Aging
Clayton W Swanson, PhDPrincipal InvestigatorNorth Florida/South Georgia Veterans Health System, Gainesville, FL

Media Library

Locomotor Learning Clinical Trial Eligibility Overview. Trial Name: NCT05475236 — N/A
Aging Research Study Groups: Sham Stimulation, Transcranial Direct Current Simulation
Aging Clinical Trial 2023: Locomotor Learning Highlights & Side Effects. Trial Name: NCT05475236 — N/A
Locomotor Learning 2023 Treatment Timeline for Medical Study. Trial Name: NCT05475236 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there a recruitment phase for this scientific investigation currently underway?

"The trial, which had its last update on November 8th 2022 and was initially posted in December 15th 2022, is not currently seeking participants. Nonetheless, there are 246 other trials that welcome enrolment at the moment."

Answered by AI
~17 spots leftby Nov 2024